Oppenheimer Initiates Coverage on BMP Sunstone (BJGP) with an Outperform
More News related to BJGP
- BMP Sunstone to Present at Piper Jaffray Health Care Conference
- BMP Sunstone to Present at LCM Healthcare Conference
- Pfizer, BMP Sunstone Announce Collaboration on Women's Healthcare Product
- BMP Sunstone (BJGP) Reports In-line Results for Q3; Guides Below for FY Revenues
- BMP Sunstone Reports Third Quarter 2009 Financial Results
More News related to New Coverage
- Top 10 News Items 11/30-12/04: Non-Farm Payrolls Much Better-Than-Expected, Comcast to Take 51% Stake in NBC Universal, BofA to Repay $45B in TARP Funds
- Trading Radar for 12/7: Kroger (KR), Pep Boys (PBY), Krispy Kreme (KKD), Casey's General Stores (CASY) Report
- Unusual 11 Mid-Day Movers 12/04: BIG, FLOW, SNV, OCLS Higher; TTWO, ZIOP, VSNT, SWHC Lower
- Notable ETF Movers 12/04: UUP, UNG Up; XME, GDX, GLD, SLV Down
- Notable Analyst Rating Changes 12/04: BAC, SNV, FSLR, AKAM Upgraded; TTWO, SWHC, AKS, NFLX Downgraded
Oppenheimer initiates coverage on BMP Sunstone (Nasdaq: BJGP) with an Outperform. Price target $6.
To see more analyst ratings on BJGP Click Here.
BMP Sunstone Corporation, formerly Beijing Med-Pharm Corporation, is a specialty pharmaceutical company with over-the-counter (OTC) manufacturing, marketing and distribution based in China.
Related Categories
New CoverageStocks Mentioned
+0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
